Global Cardiac Biomarkers Market Research Report: Information by Type (Troponins (T and I), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), ALT/AST), by Application (Myo

Global Cardiac Biomarkers Market Research Report: Information by Type (Troponins (T and I), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), ALT/AST), by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis), by Location of Testing (Point of Care, Laboratory Testing), and by Region (Americas, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027

Global Cardiac Biomarkers Market Research Report—Forecast till 2027

Market Dynamics

The global cardiac biomarkers market is expected to exhibit the highest CAGR of 16.36% during the review period of 2020 to 2027 owing to the largest value of USD 4236.02 Million in 2019. The overall cardiac biomarkers market is moderately isolated with rising competition, thing dispatches, rising aggregate affiliations, and other key decisions that are embraced to achieve useful usefulness. The vendors battle reliant upon cost, quality, optimal availability, and constancy of things promoted. The advancement of key market players is dependent upon financial circumstances, government support, and industry improvement. For example, COVID-19 has accepted a critical part in the addition of pursued cardiac biomarkers.

The cardiac biomarkers are primarily used as a coordinated demonstrative methodology for different cardiovascular illnesses. The key factors that drive the cardiac biomarkers market are the expanding commonness of cardiovascular illnesses and way of life infections, expanding pervasiveness of cardiovascular sicknesses and way of life illnesses, expansion sought after for sickness explicit therapy and exploration in which cardiac biomarkers are utilized, innovative headways in cardiac biomarkers, and great government drives to make mindfulness identified with cardiovascular sicknesses. Nonetheless, an absence of mindfulness among individuals is relied upon to hamper market development.

Segmental Overview

The global Cardiac biomarkers market has been classified into Type, application, and location of testing.

By Type segment the market has been classified into cardiac biomarker type - Creatine Kinase (CK-MB), Troponins T and I, myoglobin, BNPs, IMA, and others. By Application segment, the market is divided into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. In terms of the location of the testing, the segment is segmented as point-of-care testing and laboratory testing.

Regional Analysis

Geographically, the global cardiac biomarker market has been classified into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

Americas is likely to dominate the global cardiac biomarker market owing to the increasing demand for cardiac testing, increasing prevalence of CVD rate, and the increasing awareness of cardiac diagnostics solutions. The regional market growth is attributed to the high rate of cardiovascular diseases & diabetes, product launch, and acquisition in this region.

The market in Asia-Pacific is rising at the fastest CAGR owing to modernization, increasing disposable incomes, and rising affordability for advanced cardiac treatments. The regional market growth is driven by the rising prevalence of cardiovascular diseases, COPD, and diabetes.

Major Players

The key market players in the global cardiac biomarkers market include Novartis AG (Switzerland), Quidel Corporation (US), Trivitron Healthcare (India), F. Hoffman La Roche Ltd (Switzerland), Johnson & Johnson Services Inc. (US), Abbott Laboratories (US), Siemens (Germany), Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories, Inc (US), Danaher Corporation (US), ACS Biomarker B.V (Netherlands), Randox Laboratories Ltd (UK), and Biomérieux SA (France).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.


1 Executive Summary
2 Market Introduction
2.1 Scope Of The Study
2.2 Research Objective
2.3 Market Structure
2.4 Assumptions & Limitations
3 Research Methodology
3.1 Data Mining
3.2 Secondary Research
3.3 Primary Research
3.4 Breakdown Of Primary Respondents
3.5 Forecasting Techniques
3.6 Research Methodology For Market Size Estimation
3.6.1 Bottom-up Approach
3.6.2 Top-down Approach
3.7 Data Triangulation
3.8 Validation
4 Market Dynamics
4.1 Overview
4.2 Drivers
4.2.1 Increasing Prevalence Of Cardiovascular Disease And Lifestyle Related Diseases
4.2.2 Increase In Demand For Disease-specific Treatment & Research In Which Cardiac Biomarkers Are Used
4.3 Restraints
4.3.1 Lack Of Awareness Among People
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D And Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-sales Monitoring
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power Of Suppliers
5.2.2 Bargaining Power Of Buyers
5.2.3 Threat Of New Entrants
5.2.4 Threat Of Substitutes
5.2.5 Intensity Of Rivalry
5.3 Covid-19 Impact Analysis
6 Global Cardiac Biomarkers Market, By Type
6.1 Overview
6.2 Troponins (T And I)
6.3 Myocardial Muscle Creatine Kinase (Ck-mb)
6.4 Myoglobin
6.5 Brain Natriuretic Peptide (Bnps) Or Nt-probnp
6.6 Ischemia Modified Albumin (Ima)
6.7 Alt/Ast
6.8 Others
7 Global Cardiac Biomarkers Market, By Application
7.1 Overview
7.2 Myocardial Infarction
7.3 Congestive Heart Failure
7.4 Acute Coronary Syndrome
7.5 Atherosclerosis
7.6 Others
8 Global Cardiac Biomarkers Market, By Location Of Testing
8.1 Overview
8.2 Point Of Care Testing
8.3 Laboratory Testing
9 Global Cardiac Biomarkers Market, By Region
9.1 Overview
9.2 Americas
9.2.1 North America
9.2.1.1 Us
9.2.1.2 Canada
9.2.2 Latin America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 Uk
9.3.1.3 France
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest Of Western Europe
9.3.2 Eastern Europe
9.4 Asia-pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 South Korea
9.4.5 Australia
9.4.6 Rest Of Asia-pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
10 Competitive Landscape
10.1 Overview
10.2 Major Players In The Global Cardiac Biomarkers Market
11 Company Profiles
11.1 Novartis Ag
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products/Services Offered
11.1.4 Key Developments
11.1.5 Swot Analysis
11.1.6 Key Strategies
11.2 Quidel Corporation
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products/Services Offered
11.2.4 Key Developments
11.2.5 Swot Analysis
11.2.6 Key Strategies
11.3 Acs Biomarker B.V.
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products/Services Offered
11.3.4 Key Developments
11.3.5 Swot Analysis
11.3.6 Key Strategies
11.4 Randox Laboratories Ltd
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products/Services Offered
11.4.4 Key Developments
11.4.5 Swot Analysis
11.4.6 Key Strategies
11.5 Trivitron Healthcare
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products/Services Offered
11.5.4 Key Developments
11.5.5 Swot Analysis
11.5.6 Key Strategies
11.6 F. Hoffman La Roche Ltd
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products/Services Offered
11.6.4 Key Developments
11.6.5 Swot Analysis
11.6.6 Key Strategies
11.7 Johnson & Johnson Services Inc.
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products/Services Offered
11.7.4 Key Developments
11.7.5 Swot Analysis
11.7.6 Key Strategies
11.8 Abbott Laboratories
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products/Services Offered
11.8.4 Key Developments
11.8.5 Swot Analysis
11.8.6 Key Strategies
11.9 Siemens
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products/Services Offered
11.9.4 Key Developments
11.9.5 Swot Analysis
11.9.6 Key Strategies
11.10 Thermo Fisher Scientific Inc.
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products/Services Offered
11.10.4 Key Developments
11.10.5 Swot Analysis
11.10.6 Key Strategies
11.11 Bio-rad Laboratories, Inc.
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Products/Services Offered
11.11.4 Key Developments
11.11.5 Swot Analysis
11.11.6 Key Strategies
11.12 Danaher Corporation
11.12.1 Company Overview
11.12.2 Financial Overview
11.12.3 Products/Services Offered
11.12.4 Key Developments
11.12.5 Swot Analysis
11.12.6 Key Strategies
11.13 Biomérieux Sa
11.13.1 Company Overview
11.13.2 Financial Overview
11.13.3 Products/Services Offered
11.13.4 Key Developments
11.13.5 Swot Analysis
11.13.6 Key Strategies
12 Appendix
12.1 References
12.2 Related Report
List Of Tables
Table 1 List Of Assumptions & Limitations
Table 2 Primary Interviews And Information Gathering Process
Table 3 Global Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 4 Global Cardiac Biomarkers Market For Troponins (T And I), By Region, 2017–2027(Usd Million)
Table 5 Global Cardiac Biomarkers Market For Myocardial Muscle Creatine Kinase (Ck-mb), By Region,
2017–2027 (Usd Million)
Table 6 Global Cardiac Biomarkers Market For Myoglobin, By Region, 2017–2027 (Usd Million)
Table 7 Global Cardiac Biomarkers Market For Brain Natriuretic Peptide (Bnps) Or Nt-probnp, By Region,
2017–2027 (Usd Million)
Table 8 Global Cardiac Biomarkers Market For Ischemia Modified Albumin (Ima), By Region, 2017–2027 (Usd Million)
Table 9 Global Cardiac Biomarkers Market For Alt/Ast, By Region, 2017–2027 (Usd Million)
Table 10 Global Cardiac Biomarkers Market For Others, By Region, 2017–2027 (Usd Million)
Table 11 Global Cardiac Biomarkers Market, By Application, 2017–2027 (Usd Million)
Table 12 Global Cardiac Biomarkers Market For Myocardial Infarction, By Region, 2017–2027 (Usd Million)
Table 13 Global Cardiac Biomarkers Market For Congestive Heart Failure, By Region, 2017–2027 (Usd Million)
Table 14 Global Cardiac Biomarkers Market For Acute Coronary Syndrome, By Region, 2017–2027 (Usd Million)
Table 15 Global Cardiac Biomarkers Market For Atherosclerosis, By Region, 2017–2027(Usd Million)
Table 16 Global Cardiac Biomarkers Market For Others, By Region, 2017–2027 (Usd Million)
Table 17 Global Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 18 Global Cardiac Biomarkers Market For Point Of Care Testing, By Region, 2017–2027 (Usd Million)
Table 19 Global Cardiac Biomarkers Market For Laboratory Testing, By Region, 2017–2027 (Usd Million)
Table 20 Global Cardiac Biomarkers Market, By Region, 2017–2027 (Usd Million)
Table 21 Americas Cardiac Biomarkers Market, By Region, 2017–2027 (Usd Million)
Table 22 Americas Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 23 Americas Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 24 Americas Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 25 North America Cardiac Biomarkers Market, By Country, 2017–2027 (Usd Million)
Table 26 North America Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 27 North America Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 28 North America Cardiac Biomarkers Market, By Location Of Testing, 2017–2027(Usd Million)
Table 29 Us Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 30 Us Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 31 Us Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 32 Canada Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 33 Canada Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 34 Canada Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 35 Latin America Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 36 Latin America Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 37 Latin America Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 38 Europe Cardiac Biomarkers Market, By Region, 2017–2027 (Usd Million)
Table 39 Europe Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 40 Europe Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 41 Europe Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 42 Western Europe Cardiac Biomarkers Market, By Country, 2017–2027 (Usd Million)
Table 43 Western Europe Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 44 Western Europe Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 45 Western Europe Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 46 Germany Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 47 Germany Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 48 Germany Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 49 Uk Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 50 Uk Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 51 Uk Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 52 France Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 53 France Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 54 France Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 55 Italy Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 56 Italy Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 57 Italy Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 58 Spain Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 59 Spain Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 60 Spain Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 61 Rest Of Western Europe Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 62 Rest Of Western Europe Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 63 Rest Of Western Europe Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 64 Eastern Europe Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 65 Eastern Europe Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 66 Eastern Europe Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 67 Asia-pacific Cardiac Biomarkers Market, By Country, 2017–2027 (Usd Million)
Table 68 Asia-pacific Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 69 Asia-pacific Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 70 Asia-pacific Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 71 China Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 72 China Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 73 China Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 74 India Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 75 India Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 76 India Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 77 Japan Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 78 Japan Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 79 Japan Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 80 South Korea Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 81 South Korea Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 82 South Korea Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 83 Australia Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 84 Australia Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 85 Australia Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 86 Rest Of Asia-pacific Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 87 Rest Of Asia-pacific Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 88 Rest Of Asia-pacific Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 89 Middle East & Africa Cardiac Biomarkers Market, By Region, 2017–2027 (Usd Million)
Table 90 Middle East & Africa Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 91 Middle East & Africa Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 92 Middle East & Africa Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 93 Middle East Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 94 Middle East Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 95 Middle East Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 96 Africa Cardiac Biomarkers Market, By Type, 2017–2027 (Usd Million)
Table 97 Africa Cardiac Biomarkers, By Application, 2017–2027 (Usd Million)
Table 98 Africa Cardiac Biomarkers Market, By Location Of Testing, 2017–2027 (Usd Million)
Table 99 Major Players In The Global Cardiac Biomarkers Market
Table 100 Novartis Ag: Products/Services Offered
Table 101 Quidel Corporation: Products/Services Offered
Table 102 F. Hoffman La Roche Ltd: Products/Services Offered
Table 103 Randox Laboratories Ltd: Products/Services Offered
Table 104 Trivitron Healthcare: Products/Services Offered
Table 105 F. Hoffman La Roche Ltd: Products/Services Offered
Table 106 Johnson & Johnson Services Inc.: Products/Services Offered
Table 107 Abbott Laboratories: Products/Services Offered
Table 108 Siemens: Products/Services Offered
Table 109 Thermo Fisher Scientific Inc.: Products/Services Offered
Table 110 Bio-rad Laboratories, Inc.: Products/Services Offered
Table 111 Danaher Corporation: Products/Services Offered
Table 112 Biomérieux Sa: Products/Services Offered
List Of Figures
Figure 1 Market Synopsis
Figure 2 Global Cardiac Biomarkers Market Structure
Figure 3 Bottom-up And Top-down Approaches
Figure 4 Market Dynamics: Cardiac Biomarker Market
Figure 5 Drivers: Impact Analysis
Figure 6 Restraints: Impact Analysis
Figure 7 Value Chain: Cardiac Biomarkers Market
Figure 8 Porter’s Five Forces Analysis: Cardiac Biomarkers Market
Figure 9 Global Cardiac Biomarkers Market, By Type, 2019 & 2027 (Usd Million)
Figure 10 Global Cardiac Biomarkers Market, By Application, 2019 & 2027 (Usd Million)
Figure 11 Global Cardiac Biomarkers Market, By Location Of Testing, 2019 & 2027 (Usd Million)
Figure 12 Global Cardiac Biomarkers Market, By Region 2019 & 2027 (Usd Million)
Figure 13 Global Cardiac Biomarkers Market Share, By Region 2019 (%)
Figure 14 Americas Cardiac Biomarkers Market Share, By Region 2019 (%)
Figure 15 Western Europe Cardiac Biomarkers Market Share, By Country 2019 (%)
Figure 16 Asia-pacific Cardiac Biomarkers Market Share, By Country 2019 (%)
Figure 17 Middle East & Africa Cardiac Biomarkers Market Share, By Region 2019 (%)
Figure 18 Novartis Ag: Financial Overview Snapshot
Figure 19 Novartis Ag: Swot Analysis
Figure 20 Quidel Corporation: Financial Overview Snapshot
Figure 21 Quidel Corporation: Swot Analysis
Figure 22 Acs Biomarker B.V.: Swot Analysis
Figure 23 Randox Laboratories Ltd: Swot Analysis
Figure 24 Trivitron Healthcare: Swot Analysis
Figure 25 F. Hoffman La Roche Ltd: Financial Overview Snapshot
Figure 26 F. Hoffman La Roche Ltd: Swot Analysis
Figure 27 Johnson & Johnson Services Inc.: Financial Overview Snapshot
Figure 28 Johnson & Johnson Services Inc.: Swot Analysis
Figure 29 Abbott Laboratories: Financial Overview Snapshot
Figure 30 Abbott Laboratories: Swot Analysis
Figure 31 Siemens: Financial Overview Snapshot
Figure 32 Siemens: Swot Analysis
Figure 33 Thermo Fisher Scientific Inc.: Financial Overview Snapshot
Figure 34 Thermo Fisher Scientific Inc.: Swot Analysis
Figure 35 Bio-rad Laboratories, Inc.: Financial Overview Snapshot
Figure 36 Bio-rad Laboratories, Inc.: Swot Analysis
Figure 37 Danaher Corporation: Financial Overview Snapshot
Figure 38 Danaher Corporation: Swot Analysis
Figure 39 Biomérieux Sa: Financial Overview Snapshot
Figure 40 Biomérieux Sa: Swot Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook